Lavanya Visvabharathy

5PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersMolecular targetsAutoimmunityPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 30, 2026
Post-COVID impairment of T cell responses to community-acquired pathogens can be modified by activating cellular metabolism.

|Feb 09, 2026
IL-6R blockade with tocilizumab disrupts pericyte- and tumor cell-driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer.

Róża Przanowska, Jacky Gomez-Villa, Victoria J Liu

|Jan 09, 2026
Post-COVID impairment of memory T cell responses to community-acquired pathogens can be rectified by activating cellular metabolism.

Daniel D Carroll, Kamacay Cira, Jack Archer

|Aug 26, 2024
Mild Primary or Breakthrough SARS-CoV-2 Infection Promotes Autoantibody Production in Individuals with and without Neuro-PASC.

Lavanya Visvabharathy, Neda Dalil, Lucia Leonor

|Mar 08, 2022
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.

Barbara A Hanson, Lavanya Visvabharathy, Sareen T Ali

Pageof 1

Frequent Collaborators

2 joint publications

Igor J Koralnik

1 joint publications

Zachary S Orban

1 joint publications

Ayush Batra

1 joint publications

Eric M Liotta